- Waters Corporation recently disclosed that Senior Vice President of the Waters Analytical Sciences Division, Robert L. Carpio III, resigned in August 2026, with Tina Wu, currently Senior Vice President of the Waters Materials Sciences Division and President, China, and a former DuPont executive, stepping into the role.
- Wu’s appointment brings more than two decades of large-scale, business-to-business leadership experience, potentially reshaping how Waters aligns its analytical sciences operations with global growth opportunities and customer needs.
- We’ll now examine how Tina Wu’s move into the Analytical Sciences leadership role could influence Waters’ existing investment narrative.
Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
Waters Investment Narrative Recap
To own Waters, you need to believe its core chromatography and mass spectrometry franchise, plus the planned BD Biosciences and Diagnostic Solutions deal, can offset margin pressure, competition, and funding headwinds. Tina Wu’s move into Analytical Sciences does not appear to materially change the near term integration catalyst or the main risks around executing that large combination and defending Waters’ premium positioning.
The most relevant recent announcement is the company’s updated 2026 revenue guidance of US$6.415 billion to US$6.476 billion, which frames how much room Waters has to absorb leadership changes while still pursuing integration and synergy targets from the BD transaction. How effectively Wu steers Analytical Sciences will matter for sustaining the product strength that underpins those revenue ambitions and any future cross selling upside.
Yet, against that potential, investors should also be aware that if integration slips or synergies underdeliver, the downside to margins and earnings could...
Read the full narrative on Waters (it's free!)
Waters' narrative projects $7.8 billion revenue and $1.3 billion earnings by 2029.
Uncover how Waters' forecasts yield a $413.26 fair value, in line with its current price.
Exploring Other Perspectives
Some of the most optimistic analysts were assuming Waters could reach about US$8.6 billion of revenue and US$1.6 billion of earnings by 2029, so Wu’s appointment could either reinforce that bullish view or prompt a rethink of how exposed Waters is to disruptive digital and AI powered lab platforms and what that means for your own expectations.
Explore 4 other fair value estimates on Waters - why the stock might be worth as much as 17% more than the current price!
Decide For Yourself
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Waters research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
- Our free Waters research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Waters' overall financial health at a glance.
Interested In Other Possibilities?
The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:
- Find 51 companies with promising cash flow potential yet trading below their fair value.
- AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- The future of work is here. Discover the 38 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com